Literature DB >> 20835846

A novel composition for the culture of human adipose stem cells which includes complement C3.

Sangeetha Hareendran1, Solomon Sathishkumar, Salar Abbas, Alastair M Mackay, Prithi Rajan.   

Abstract

Adipose tissue is an easily accessible and abundant source of stem cells. Adipose stem cells (ASCs) are currently being researched as treatment options for repair and regeneration of damaged tissues. The standard culture conditions used for expansion of ASCs contain fetal bovine serum (FBS) which is undefined, could transmit known and unknown adventitious agents, and may cause adverse immune reactions. We have described a novel culture condition which excludes the use of FBS and characterised the resulting culture. Human ASCs were cultured in the novel culture medium, which included complement protein C3. These cultures, called C-ASCs, were compared with ASCs cultured in medium supplemented with FBS. Analysis of ASCs for surface marker profile, proliferation characteristics and differentiation potential indicated that the C-ASCs were similar to ASCs cultured in medium containing FBS. Using a specific inhibitor, we show that C3 is required for the survival of C-ASCs. This novel composition lends itself to being developed into a defined condition for the routine culture of ASCs for basic and clinical applications.

Entities:  

Year:  2010        PMID: 20835846      PMCID: PMC2993860          DOI: 10.1007/s10616-010-9301-1

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  49 in total

1.  Immunophenotype of human adipose-derived cells: temporal changes in stromal-associated and stem cell-associated markers.

Authors:  James B Mitchell; Kevin McIntosh; Sanjin Zvonic; Sara Garrett; Z Elizabeth Floyd; Amy Kloster; Yuan Di Halvorsen; Robert W Storms; Brian Goh; Gail Kilroy; Xiying Wu; Jeffrey M Gimble
Journal:  Stem Cells       Date:  2005-12-01       Impact factor: 6.277

2.  Binding of C3 and C3dg to the CR2 complement receptor induces growth of an Epstein-Barr virus-positive human B cell line.

Authors:  A Hatzfeld; E Fischer; J P Levesque; R Perrin; J Hatzfeld; M D Kazatchkine
Journal:  J Immunol       Date:  1988-01-01       Impact factor: 5.422

3.  Comparison of human stem cells derived from various mesenchymal tissues: superiority of synovium as a cell source.

Authors:  Yusuke Sakaguchi; Ichiro Sekiya; Kazuyoshi Yagishita; Takeshi Muneta
Journal:  Arthritis Rheum       Date:  2005-08

4.  Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.

Authors:  Wolfgang Wagner; Frederik Wein; Anja Seckinger; Maria Frankhauser; Ute Wirkner; Ulf Krause; Jonathon Blake; Christian Schwager; Volker Eckstein; Wilhelm Ansorge; Anthony D Ho
Journal:  Exp Hematol       Date:  2005-11       Impact factor: 3.084

5.  Complement: a novel factor in basal and ischemia-induced neurogenesis.

Authors:  Yalda Rahpeymai; Max Albert Hietala; Ulrika Wilhelmsson; Andrew Fotheringham; Ioan Davies; Ann-Katrin Nilsson; Jörg Zwirner; Rick A Wetsel; Craig Gerard; Milos Pekny; Marcela Pekna
Journal:  EMBO J       Date:  2006-02-23       Impact factor: 11.598

6.  Culture effects of epidermal growth factor (EGF) and basic fibroblast growth factor (bFGF) on cryopreserved human adipose-derived stromal/stem cell proliferation and adipogenesis.

Authors:  Teddi L Hebert; Xiying Wu; Gang Yu; Brian C Goh; Yuan-Di C Halvorsen; Zhong Wang; Cedric Moro; Jeffrey M Gimble
Journal:  J Tissue Eng Regen Med       Date:  2009-10       Impact factor: 3.963

7.  Adipose-derived mesenchymal stem cells ameliorate chronic experimental autoimmune encephalomyelitis.

Authors:  Gabriela Constantin; Silvia Marconi; Barbara Rossi; Stefano Angiari; Laura Calderan; Elena Anghileri; Beatrice Gini; Simone Dorothea Bach; Marianna Martinello; Francesco Bifari; Mirco Galiè; Ermanna Turano; Simona Budui; Andrea Sbarbati; Mauro Krampera; Bruno Bonetti
Journal:  Stem Cells       Date:  2009-10       Impact factor: 6.277

8.  Rapid expansion of human adipose-derived stromal cells preserving multipotency.

Authors:  H Suga; T Shigeura; D Matsumoto; K Inoue; H Kato; N Aoi; S Murase; K Sato; K Gonda; I Koshima; K Yoshimura
Journal:  Cytotherapy       Date:  2007       Impact factor: 5.414

9.  Human marrow-derived mesenchymal progenitor cells: isolation, culture expansion, and analysis of differentiation.

Authors:  Edward J Caterson; Leon J Nesti; Keith G Danielson; Rocky S Tuan
Journal:  Mol Biotechnol       Date:  2002-03       Impact factor: 2.860

10.  The proinflammatory mediators C3a and C5a are essential for liver regeneration.

Authors:  Christoph W Strey; Maciej Markiewski; Dimitrios Mastellos; Ruxandra Tudoran; Lynn A Spruce; Linda E Greenbaum; John D Lambris
Journal:  J Exp Med       Date:  2003-09-15       Impact factor: 14.307

View more
  4 in total

Review 1.  Complement activation in the context of stem cells and tissue repair.

Authors:  Ingrid U Schraufstatter; Sophia K Khaldoyanidi; Richard G DiScipio
Journal:  World J Stem Cells       Date:  2015-09-26       Impact factor: 5.326

2.  Role of medullary progenitor cells in epithelial cell migration and proliferation.

Authors:  Dong Chen; Zhiyong Chen; Yuning Zhang; Chanyoung Park; Ahmed Al-Omari; Gilbert W Moeckel
Journal:  Am J Physiol Renal Physiol       Date:  2014-05-07

3.  A Novel S100A8/A9 Induced Fingerprint of Mesenchymal Stem Cells associated with Enhanced Wound Healing.

Authors:  Abhijit Basu; Saira Munir; Medanie A Mulaw; Karmveer Singh; Diana Crisan; Anca Sindrilaru; Nicolai Treiber; Meinhard Wlaschek; Markus Huber-Lang; Florian Gebhard; Karin Scharffetter-Kochanek
Journal:  Sci Rep       Date:  2018-04-18       Impact factor: 4.379

4.  Clinical analysis of selected complement-derived molecules in human adipose tissue.

Authors:  Wojciech Błogowski; Marta Budkowska; Daria Sałata; Karol Serwin; Barbara Dołęgowska; Marek Łokaj; Piotr Prowans; Teresa Starzyńska
Journal:  J Transl Med       Date:  2013-01-09       Impact factor: 5.531

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.